Genetic stratification in myeloid diseases: from risk assessment to clinical decision support tool.

about

Genetic stratification in myeloid diseases: from risk assessment to clinical decision support tool.

Item

http://www.wikidata.org/entity/Q39100115

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Genetic stratification in myel ...... linical decision support tool.

@en

Genetic stratification in myel ...... linical decision support tool.

@nl

type

Item

label

Genetic stratification in myel ...... linical decision support tool.

@en

Genetic stratification in myel ...... linical decision support tool.

@nl

prefLabel

Genetic stratification in myel ...... linical decision support tool.

@en

Genetic stratification in myel ...... linical decision support tool.

@nl

P1476

Genetic stratification in myel ...... linical decision support tool.

@en

P2093

Yishai Ofran

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML

Impact of FLT3(ITD) mutant allele level on relapse risk in intermediate-risk acute myeloid leukemia.

P304

e0025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5041/RMMJ.10159

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yishai Ofran

P577

2014-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268234932

http://www.w3.org/2001/XMLSchema#string

P698

25386341

http://www.w3.org/2001/XMLSchema#string

P932

4222414

http://www.w3.org/2001/XMLSchema#string